University of California San Francisco | About UCSF | UCSF Benioff Children's Hospital San Francisco
Search Site | Find a Doctor

Gregory Marcus, M.D.

Cardiologist and electrophysiologist

Dr. Gregory Marcus is a specialist in the treatment of arrhythmias, including mapping and catheter ablation for atrial fibrillation, supraventricular tachycardias and ventricular arrhythmias. He is also an expert in pacemaker, biventricular device and defibrillator implantation. Marcus also researches atrial arrhythmias, specifically serologic markers and genetic factors important to the disease. He is the principle investigator on research grants awarded by the National Institutes of Health and the American Heart Association.

Marcus earned his medical degree from George Washington University School of Medicine and Health Sciences. He completed an internship and residency in medicine at Stanford University Medical Center. Marcus then completed his training in cardiovascular medicine and cardiovascular electrophysiology at UCSF before joining the faculty as an assistant professor of medicine in 2006.

Clinics

Cardiac Electrophysiology and Arrhythmia Service
400 Parnassus Ave., Floor B1, Room 094
San Francisco, CA 94143
Phone: (415) 353-2554
Fax: (415) 353-2528

Hours: Monday to Friday
8 a.m. – 5 p.m.

Cardiovascular Genetics Program
400 Parnassus Avenue, Plaza Level, Room 94
San Francisco, CA 94143
Phone: (415) 353-2873
Fax: (415) 476-5355

Hours: Monday
noon – 4 p.m

Conditions & Treatments

More about Gregory Marcus

Education

George Washington University School of Medicine 1998

Residencies

Stanford Hospital and Clinics, Internal Medicine 2002
UCSF Medical Center, Cardiology 2004

Fellowships

UCSF Medical Center, Cardiac Electrophysiology 2006

Selected Research and Publications

  1. Stepanyan G, Badhwar N, Lee RJ, Marcus GM, Lee BK, Tseng ZH, Vedantham V, Olgin J, Scheinman M, Gerstenfeld EP. Safety of new oral anticoagulants for patients undergoing atrial fibrillation ablation. J Interv Card Electrophysiol. 2014 Jun; 40(1):33-8.
  2. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Executive summary: heart disease and stroke statistics--2014 update: a report from the american heart association. Circulation. 2014 Jan 21; 129(3):399-410.
  3. Dukes JW, Marcus GM. Atrial fibrillation begets myocardial infarction. JAMA Intern Med. 2014 Jan 1; 174(1):5-7.
  4. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, Dai S, Ford ES, Fox CS, Franco S, Fullerton HJ, Gillespie C, Hailpern SM, Heit JA, Howard VJ, Huffman MD, Judd SE, Kissela BM, Kittner SJ, Lackland DT, Lichtman JH, Lisabeth LD, Mackey RH, Magid DJ, Marcus GM, Marelli A, Matchar DB, McGuire DK, Mohler ER, Moy CS, Mussolino ME, Neumar RW, Nichol G, Pandey DK, Paynter NP, Reeves MJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Wong ND, Woo D, Turner MB. Heart disease and stroke statistics--2014 update: a report from the american heart association. Circulation. 2014 Jan 21; 129(3):e28-e292.
  5. Roberts JD, Hsu JC, Aouizerat BE, Pullinger CR, Malloy MJ, Kane JP, Olgin JE, Marcus GM. Impact of a 4q25 genetic variant in atrial flutter and on the risk of atrial fibrillation after cavotricuspid isthmus ablation. J Cardiovasc Electrophysiol. 2014 Mar; 25(3):271-7.
  6. Marcus GM, Dewland TA. The calculated risk of defibrillator implantation. J Am Coll Cardiol. 2014 Mar 4; 63(8):797-8.
  7. Dewland TA, Vittinghoff E, Mandyam MC, Heckbert SR, Siscovick DS, Stein PK, Psaty BM, Sotoodehnia N, Gottdiener JS, Marcus GM. Atrial ectopy as a predictor of incident atrial fibrillation: a cohort study. Ann Intern Med. 2013 Dec 3; 159(11):721-8.
  8. Marcus GM, Keung E, Scheinman MM. The year in review of clinical cardiac electrophysiology. J Am Coll Cardiol. 2013 Dec 24; 62(25):2433-47.
  9. Dewland TA, Olgin JE, Vittinghoff E, Marcus GM. Incident atrial fibrillation among asians, hispanics, blacks, and whites. Circulation. 2013 Dec 3; 128(23):2470-7.
  10. McCabe JM, Armstrong EJ, Ku I, Kulkarni A, Hoffmayer KS, Bhave PD, Waldo SW, Hsue P, Stein JC, Marcus GM, Kinlay S, Ganz P. Physician accuracy in interpreting potential ST-segment elevation myocardial infarction electrocardiograms. J Am Heart Assoc. 2013 Oct; 2(5):e000268.
  11. Dewland TA, Scheinman MM, Marcus GM. Supraventricular tachycardia termination after atrial noncapture: What is the mechanism? Heart Rhythm. 2014 Jun; 11(6):1085-6.
  12. Hsu JC, Badhwar N, Gerstenfeld EP, Lee RJ, Mandyam MC, Dewland TA, Imburgia KE, Hoffmayer KS, Vedantham V, Lee BK, Tseng ZH, Scheinman MM, Olgin JE, Marcus GM. Randomized trial of conventional transseptal needle versus radiofrequency energy needle puncture for left atrial access (the TRAVERSE-LA study). J Am Heart Assoc. 2013 Oct; 2(5):e000428.
  13. Soleimani Rahbar A, Hsu JC, Han FT, Nguyen N, Kwon M, Azadani PN, Marcus GM, Lee BK. Trainee inexperience is associated with longer procedure times but no increase in complications for cardiac device implantation. Heart Rhythm. 2013 Dec; 10(12):1755-8.
  14. Hsu JC, Varosy PD, Bao H, Dewland TA, Curtis JP, Marcus GM. Cardiac perforation from implantable cardioverter-defibrillator lead placement: insights from the national cardiovascular data registry. Circ Cardiovasc Qual Outcomes. 2013 Sep 1; 6(5):582-90.
  15. Mandyam MC, Soliman EZ, Alonso A, Dewland TA, Heckbert SR, Vittinghoff E, Cummings SR, Ellinor PT, Chaitman BR, Stocke K, Applegate WB, Arking DE, Butler J, Loehr LR, Magnani JW, Murphy RA, Satterfield S, Newman AB, Marcus GM. The QT interval and risk of incident atrial fibrillation. Heart Rhythm. 2013 Oct; 10(10):1562-8.
  16. Dewland TA, Hsu JC, Castellanos JM, Smith LM, Marcus GM. Consideration of patient age and life expectancy in implantable cardioverter-defibrillator referral. Am Heart J. 2013 Jul; 166(1):164-70.
  17. Rahmutula D, Marcus GM, Wilson EE, Ding CH, Xiao Y, Paquet AC, Barbeau R, Barczak AJ, Erle DJ, Olgin JE. Molecular basis of selective atrial fibrosis due to overexpression of transforming growth factor-1. Cardiovasc Res. 2013 Sep 1; 99(4):769-79.
  18. Mandyam MC, Soliman EZ, Heckbert SR, Vittinghoff E, Marcus GM. Long-term outcomes of left anterior fascicular block in the absence of overt cardiovascular disease. JAMA. 2013 Apr 17; 309(15):1587-8.
  19. Hsu JC, Li Y, Marcus GM, Hsue PY, Scherzer R, Grunfeld C, Shlipak MG. Atrial fibrillation and atrial flutter in human immunodeficiency virus-infected persons: incidence, risk factors, and association with markers of HIV disease severity. J Am Coll Cardiol. 2013 Jun 4; 61(22):2288-95.
  20. Marcus GM, Keung E, Scheinman MM. The year in review of clinical cardiac electrophysiology. J Am Coll Cardiol. 2013 Feb 19; 61(7):772-82.

Publications are derived from MEDLINE/PubMed and provided by UCSF Profiles, a service of the Clinical & Translational Science Institute (CTSI) at UCSF. Researchers can make corrections and additions to their publications by logging on to UCSF Profiles.